Sanofi And Amgen Make The Case For OX40 Drugs In Atopic Dermatitis

Two Therapies That Could Rival Dupixent

 
• By Kevin Grogan
  
two planes
Two new atopic dermatitis drugs soar at EADV congress • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immunological

More from Therapeutic Category